Momelotinib is a pharmaceutical raw material used in the manufacturing of medications for myelofibrosis. It functions as a Janus kinase inhibitor and is administered orally.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1622902-68-4
Peficitinib
pharmaceutical raw material
Baricitinib
pharmaceutical raw material
Upadacitinib
pharmaceutical raw material
Fingolimod
pharmaceutical raw material
Fingolimod hydrochloride
pharmaceutical raw material
Roflumilast
pharmaceutical raw material
3-Methoxy-4-(difluoromethoxy)benzaldehyde
pharmaceutical raw material
Despropanesulfonyl Abrocitinib
pharmaceutical intermediate
N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
IUEWXNHSKRWHDY-UHFFFAOYSA-N
CCCS(=O)(=O)NC1CC(C1)N(C)C2=NC=NC3=C2C=CN3